These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3465966)

  • 21. [Immunologic subclassification of lymphoblastic leukemia in childhood. II. Immunologic phenotype, clinical picture and prognosis].
    Kołecki P
    Acta Haematol Pol; 1986; 17(3-4):103-9. PubMed ID: 3473885
    [No Abstract]   [Full Text] [Related]  

  • 22. [The significance of immunofluorescence and rosette tests in the study of acute lymphoblastic leukemia in childhood].
    Nosková J; Cáp J; Babusíková O
    Cesk Pediatr; 1984 Sep; 39(9):513-7. PubMed ID: 6391703
    [No Abstract]   [Full Text] [Related]  

  • 23. B-cell markers on lymphoblasts in acute lymphoblastic leukaemia.
    Gajl-Peczalska KJ; Bloomfield CD; Nesbit ME; Kersey JH
    Clin Exp Immunol; 1974 Aug; 17(4):561-9. PubMed ID: 4219600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute lymphoblastic leukemia with an abnormal T8 phenotype].
    Blanco A; Guisasola JA; Valbuena C; Solís P; Villar A; Sánchez Villares E
    Sangre (Barc); 1984; 29(3):302-9. PubMed ID: 6237441
    [No Abstract]   [Full Text] [Related]  

  • 25. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histocompatibility antigens (HLA) in acute lymphocytic leukemia.
    Ulukutlu L; Yazici H; Cam H; Esen E; Ozbakir F
    Turk J Pediatr; 1986; 28(2):111-4. PubMed ID: 3461609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relation between immunological and morphological characteristics and the clinical course in children with acute lymphoblastic leukemia].
    Kubíková A; Habancová M; Valnícek S
    Cas Lek Cesk; 1984 May; 123(19):578-82. PubMed ID: 6589048
    [No Abstract]   [Full Text] [Related]  

  • 28. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic heterogeneity of acute lymphoblastic leukemia in children detected with xenogeneic antisera].
    Baryshnikov AIu; Tupitsin NN; Morozova LF; Tumian BG; Kadagidze ZG
    Ter Arkh; 1983; 55(11):81-6. PubMed ID: 6581572
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell surface markers in acute lymphoblastic leukemia.
    Humphrey GB; Blackstock R; Filler J
    Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levels of Epstein-Barr virus antibodies in the serum of children with acute lymphoblastic leukemia].
    Holý J; Hrodek O; Hynieová H; Petrtýlová K; Srajer J; Vanĕcek K
    Cesk Pediatr; 1981 May; 36(5):248-53. PubMed ID: 6266677
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunological classification of acute lymphoblastic leukemias (ALL) in childhood. Origin and clinical significance of phenotypic variability].
    Thöne I; Kabisch H; Müller J; Winkler K; Landbeck G
    Monatsschr Kinderheilkd; 1982 Dec; 130(12):883-90. PubMed ID: 6759928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of pre-B immunophenotype in early treatment response among acute pediatric lymphoblast leukemia patients].
    Correa-González LC; Mandeville PB; Manrique-Dueñas J; Alejo-González F; Salazar-Martínez A; de Pérez-Ramírez OJ; Hernández-Sierra JF
    Gac Med Mex; 2005; 141(6):477-82. PubMed ID: 16381501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunologic cell markers in acute lymphoblastic leukemia in children].
    Grigor'iants LIa
    Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukaemia complicating null cell acute lymphoblastic leukaemia.
    Gutteridge CN; Newland AC
    Clin Lab Haematol; 1986; 8(1):77-9. PubMed ID: 3459605
    [No Abstract]   [Full Text] [Related]  

  • 36. The heterogeneity of 5'-nucleotidase activity in lymphoblasts of acute lymphoblastic leukemia, demonstrated by an improved cytochemical method.
    Pangalis GA; Tsavaris NB; Roussou PA
    Biomed Pharmacother; 1984; 38(9-10):444-8. PubMed ID: 6099151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
    Ukaejiofo EO; Sagoe AS; Osunkoya BO
    Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
    Bogusławska-Jaworska J; Rodziewicz B
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospective study of the immunologic classification of 128 cases of acute lymphoblastic leukemia in the city of Puebla, Mexico].
    Ruiz-Argüelles GJ; Marín-López A; Ruiz-Argüelles A; Valls de Ruiz M; Pérez-Romano B; Ruiz-González DS
    Rev Invest Clin; 1987; 39(2):137-42. PubMed ID: 3310166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.